Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that he has been implementing in the country over the past 25 years. Leveraging its long-standing experience of the Ukrainian market, he also provides us with an assessment of the current market dynamics propelling the local pharmaceutical market - at the moment Ukraine’s economy shows signs of recovery.
Pharmascience was one of the first international companies to enter the Ukrainian pharmaceutical market following the country’s independence at the end of 1991. What was the market opportunity that you identified at that time?
"Ukraine holds a long-standing experience in pharmaceutical manufacturing that actually goes back to pre-independence history, when Ukraine was seen as the “breadbasket” for medicines production within the USSR."
